Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma
NCT00465179Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2007
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in non-clear cell renal cell carcinoma (nccRCC), sponsored by University of Texas MD Anderson Cancer Center. Started Mar 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
non-clear cell renal cell carcinoma (nccRCC)
Beyond the preview
Go deeper on NCT00465179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00465179.